Evidence map›Paper›PMID 37503139›Full record

ArticlebioRxiv : the preprint server for biology2023

A microfluidic strategy to capture antigen-specific high affinity B cells.

Ahmed M Alhassan, Venktesh S Shirure, Jean Luo, Bryan B Nguyen, Zachary A Rollins, Bhupinder S Shergill, Xiangdong Zhu, Nicole Baumgarth, Steven C George

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ahmed M AlhassanDepartment of Biomedical Engineering, University of California, Davis.
Venktesh S ShirureDepartment of Biomedical Engineering, University of California, Davis.
Jean LuoDepartment of Pathology, Microbiology, and Immunology, University of California, Davis.
Bryan B NguyenDepartment of Biomedical Engineering, University of California, Davis.
Zachary A RollinsDepartment of Biomedical Engineering, University of California, Davis.
Bhupinder S ShergillDepartment of Biomedical Engineering, University of California, Davis.
Xiangdong ZhuDepartment of Physics and Astronomy, University of California, Davis.
Nicole BaumgarthDepartment of Pathology, Microbiology, and Immunology, University of California, Davis.
Steven C GeorgeDepartment of Biomedical Engineering, University of California, Davis.
University of California, Davis · USJohns Hopkins University · US

Funding

Quantifying the spectrum and dynamics of B-cell binding avidity in response to influenzaR21AI161041 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMGARTH, NICOLE, GEORGE, STEVEN CARL · 2021 to 2022
$432k
NIAID NIH HHS R21 AI161041
6 · The paper itself

Abstract

Assessing B cell affinity to pathogen-specific antigens prior to or following exposure could facilitate the assessment of immune status. Current standard tools to assess antigen-specific B cell responses focus on equilibrium binding of the secreted antibody in serum. These methods are costly, time-consuming, and assess antibody affinity under zero-force. Recent findings indicate that force may influence BCR-antigen binding interactions and thus immune status. Here, we designed a simple laminar flow microfluidic chamber in which the antigen (hemagglutinin of influenza A) is bound to the chamber surface to assess antigen-specific BCR binding affinity of five hemagglutinin-specific hybridomas under 65- to 650-pN force range. Our results demonstrate that both increasing shear force and bound lifetime can be used to enrich antigen-specific high affinity B cells. The affinity of the membrane-bound BCR in the flow chamber correlates well with the affinity of the matched antibodies measured in solution. These findings demonstrate that a microfluidic strategy can rapidly assess BCR-antigen binding properties and identify antigen-specific high affinity B cells. This strategy has the potential to both assess functional immune status from peripheral B cells and be a cost-effective way of identifying individual B cells as antibody sources for a range of clinical applications.

Indexed as

affinityaviditycell separationimmunology

Identifiers

PMID37503139
PMCPMC10369944
OpenAlexW4384296364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.